SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Clinical Trials
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Goodman, S. N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodman, S. N
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Introduction

Introduction to Bayesian methods I: measuring the strength of evidence

Steven N Goodman

Department of Oncology, Division of Biostatistics, Johns Hopkins School of Medicine, 550 N. Broadway, Suite 1103, Baltimore, MD 21205, USA; sgoodman{at}jhmi.edu

Bayesian inference is a formal method to combine evidence external to a study, represented by a prior probability curve, with the evidence generated by the study, represented by a likelihood function. Because Bayes theorem provides a proper way to measure and to combine study evidence, Bayesian methods can be viewed as a calculus of evidence, not just belief. In this introduction, we explore the properties and consequences of using the Bayesian measure of evidence, the Bayes factor (in its simplest form, the likelihood ratio). The Bayes factor compares the relative support given to two hypotheses by the data, in contrast to the P-value, which is calculated with reference only to the null hypothesis. This comparative property of the Bayes factor, combined with the need to explicitly predefine the alternative hypothesis, produces a different assessment of the strength of evidence against the null hypothesis than does the P-value, and it gives Bayesian procedures attractive frequency properties. However, the most important contribution of Bayesian methods is the way in which they affect both who participates in a scientific dialogue, and what is discussed. With the emphasis moved from "error rates" to evidence, content experts have an opportunity for their input to be meaningfully incorporated, making it easier for regulatory decisions to be made correctly.

Clinical Trials, Vol. 2, No. 4, 282-290 (2005)
DOI: 10.1191/1740774505cn098oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Int J EpidemiolHome page
M. Zwahlen
Commentary: Cornfield on cigarette smoking and lung cancer and how to assess causality
Int. J. Epidemiol., October 1, 2009; 38(5): 1197 - 1198.
[Full Text] [PDF]


Home page
Clin TrialsHome page
S. Biswas, D. D Liu, J J. Lee, and D. A Berry
Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center
Clinical Trials, June 1, 2009; 6(3): 205 - 216.
[Abstract] [PDF]


Home page
Am J EpidemiolHome page
H. A. Katki
Invited Commentary: Evidence-based Evaluation of p Values and Bayes Factors
Am. J. Epidemiol., August 15, 2008; 168(4): 384 - 388.
[Abstract] [Full Text] [PDF]



Advertisement